Patent · US Active

Forms of pyrido[1,2-a]pyrimidin-4-one derivatives, its formulation and its process of making

US12122789B2 · kind B2 · utility

0Cited by
4References
31Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 16, 2021
Grant dateOct 22, 2024
Priority date
Expiry dateDec 13, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention relates to a process for the preparation of 7-(4,7-diazaspiro[2.5]octan-7-yl)-2-(2,8-dimethylimidazo[1,2-b]pyridazin-6-yl)pyrido[1,2-a]pyrimidin-4-one useful as pharmaceutically active compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.